Skip to content

Clinical trials

Phase 2/3 Recurrence trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 2/3 Country / region: France Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20161
20191
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioNTech SE1
Celgene1
ERYtech Pharma1
Geron Corporation1
Global Coalition for Adaptive Research1
Gustave Roussy, Cancer Campus, Grand Paris1
Kiniksa Pharmaceuticals International, plc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence7
Carcinoma, Squamous Cell1
Glioblastoma1
Head and Neck Neoplasms1
Lymphoma, Large B-Cell, Diffuse1
Lymphoma, Non-Hodgkin1
Myelodysplastic Syndromes1
Neoplasm Metastasis1
Pericarditis1
Precursor Cell Lymphoblastic Leukemia-Lymphoma1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.